The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback